Publications are reviewed to identify factors related to donor care that may optimize the function of pancreatic tissue (whole or segmental organ or islet cells) after transplantation. Short cold ischemia time, avoidance of hypotension, and treatment of donor hyperglycemia appear to be beneficial, although additional properly designed studies are needed to verify those findings.
Get full access to this article
View all access options for this article.
References
1.
GruessnerACSutherlandDE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003. Clin Transpl.2003:21–51.
2.
ZamanFAbreoKDLevineSMaleyWZibariGB. Pancreatic transplantation: Evaluation and management. J Intensive Care Med.2004;19:127–139.
3.
SerupPMadsenODMandrup-PoulsenT. Islet and stem cell transplantation for treating diabetes. BMJ.2001;322:29–32.
4.
RobertsonRP. Islet transplantation as a treatment for diabetes: A work in progress. N Engl J Med.2004;350:694–705.
5.
MarkmannJFDengSDesaiNM. The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation.2003;75:1423–1429.
6.
KriegerNROdoricoJSHeiseyDM. Underutilization of pancreas donors. Transplantation.2003;75:1271–1276.
7.
ClaytonHASwiftSMTurnerJMJamesRFBellPR. Non-heart-beating organ donors: A potential source of islets for transplantation?Transplantation.2000;69:2094–2098.
8.
KapurSBonhamCADodsonSFDvorchikICorryRJ. Strategies to expand the donor pool for pancreas transplantation. Transplantation.1999;67:284–290.
9.
SchmidTKönigsrainerASteinerEKollerJMargreiterR. Do donor age and cold-ischemia time have a detrimental effect on early pancreas-allograft function?Diabetes.1989;38(suppl 1):4–6.
10.
HesseUJSutherlandDER. Influence of serum amylase and plasma glucose levels in pancreas cadaver donors on graft function in recipients. Diabetes.1989;38(suppl 1):1–3.
11.
DouzdjianVGugliuzzaKGFishJC. Multivariate analysis of donor risk factors for pancreas allograft failure after simultaneous pancreas-kidney transplantation. Surgery.1995;118:73–81.
12.
GoresPFGillinghamKJDunnDLMoudry-MunnsKCNajarianJSSutherlandDE. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution's experience. Ann Surg.1992;215:217–230.
13.
StrattaRJ. Donor age, organ import, and cold ischemia: Effect on early outcomes after simultaneous kidney-pancreas transplantation. Transplant Proc.1997;29:3291–3292.
14.
GruessnerACBarrouBJonesJ. Donor impact on outcome of bladder-drained pancreas transplants. Transplant Proc.1993;25:3114–3115.
15.
van HoutenHGooszenHGvan den AkkerPJ. Plasma insulin, C-peptide, HbA1c, and plasma glucose levels in organ donors. Transplant Proc.1990;22:435–436.
16.
MassonFThicoipeMGinH. The endocrine pancreas in brain-dead donors. Transplantation.1993;56:363–367.
17.
TamsmaJTSchaapherderAFMvan BronswijkH. Islet cell hormone release immediately after human pancreatic transplantation. Transplantation.1993;56:1119–1123.
18.
ZengYTorreMAKarrisonTThistlethwaiteJR. The correlation between donor characteristics and the success of human islet isolation. Transplantation.1994;57:954–958.
19.
LakeyJRTWarnockGLRajotteRV. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation.1996;61:1047–1053.
20.
BrandhorstDHeringBJBrandhorstHFederlinKBretzelRG. Influence of donor data and organ procurement on human islet isolation. Transplant Proc.1994;26:592–593.
21.
BenhamouPYWattPCMullenY. Human islet isolation in 104 consecutive cases. Transplantation.1994;57:1804–1810.
22.
FiedorPGoodmanERSungRSShimomuraKKwiatkowskiPAHardyMA. Factors that can affect cadaveric islet graft function include hemodynamic changes in the donor prior to organ harvest. Transplant Proc.1996;28:169–170.
23.
PownerDJHernandezM. A review of thyroid hormone administration during adult donor care. Prog Transplant. In press.
24.
PownerDJ. Factors during donor care that may affect liver transplantation outcome. Prog Transplant.2004;14:241–249.
25.
BouwmanDLWeaverDWWaltAJ. Serum amylase and its isoenzymes: A clarification of their implications in trauma. J Trauma.1984;24:573–578.
26.
VitaleGCLarsonGMDavidsonPRBouwmanDLWeaverDW. Analysis of hyperamylasemia in patients with severe head injury. J Surg Res.1987;43:226–233.
27.
BouwmanDLAltshulerJWeaverDW. Hyperamylasemia: A result of intracranial bleeding. Surgery.1983;94:318–323.
28.
PezzilliRBilliPBarakatB. Serum pancreatic enzymes in patients with coma due to head injury or acute stroke. Int J Clin Lab Res.1997;27:244–246.
29.
PownerDJHendrichALaglerRGNgRHMaddenRL. Hormonal changes in brain dead patients. Crit Care Med.1990;18:702–708.
30.
CliftonGLZieglerMGGrossmanRG. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery.1981;8:10–13.
31.
YoshidaHHiraideAYoshiokaTSugimotoT. Transient suppression of pancreatic endocrine function in patients following brain death. Clin Transplant.1996;10:28–33.
32.
BrunicardiFCDyenYBrostromL. The circulating hormonal milieu of the endocrine pancreas in healthy individuals, organ donors, and the isolate perfused human pancreas. Pancreas.2000;21:203–211.
33.
AlKharfyKMKellumJAMatzkeGR. Unintended immunomodulation: Part I. Effects of common clinical conditions on cytokine biosynthesis. Shock.2000;13:333–345.
34.
ThicoipeMFavarel-GarriguesJFMassonF. Endocrine pancreas after brain death: Preliminary results. Transplant Proc.1991;23:2481–2482.
35.
GroeneveldABJBeishuizenAVisserFC. Insulin: A wonder drug in the critically ill?Crit Care.2002;6:102–105.
36.
van den BergheGWoutersPJBouillonR. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med.2003;31:359–366.
37.
PownerDJKellumJADarbyJM. Abnormalities in fluids, electrolytes, and metabolism of organ donors. Prog Transplant.2000;10:88–96.
38.
BrownGDodekP. Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med.2001;29:1714–1719.
39.
SchnuellePBergerSde BoerJPersijnGvan der WoudeFJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation.2001;72:455–463.
